Cafepharma Today

May 22 2025 - Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
FDA advisors unanimously snub Pfizer's Talzenna in broader prostate cancer population
Prices for new US drugs doubled in 4 years as focus on rare disease grows
FDA expands warnings of heart risks on COVID shots
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FDA outlines stricter Covid vaccine booster approval standards for healthy people
CNBC
Tuesday, May 20, 2025 - 11:29am
tags:
FDA, COVID-19, boosters, vaccines, clinical trials
HHS sets ‘pricing targets’ to lower U.S. drug costs: 6 things to know
Beckers Hospital Review
Tuesday, May 20, 2025 - 11:04am
tags:
HHS, Robert F Kennedy Jr., most favored nation, drug pricing
AHA warns tariffs could worsen drug shortages, pushes for long-term reform
Beckers Hospital Review
Tuesday, May 20, 2025 - 11:02am
tags:
AHA, tariffs, drug pricing, drug shortages
Surveyed via text, HCPs say they want more interactions with pharma
Medical Marketing and Media
Tuesday, May 20, 2025 - 10:26am
tags:
HCPs, physicians, physician education, pharma marketing
FDA grants clearance to BrainStorm’s Phase IIIb trial of ALS treatment
Clinical Trials Arena
Tuesday, May 20, 2025 - 10:19am
tags:
FDA, BrainStorm Cell Therapeutics, clinical trials, NurOwn, ALS
RegenXBio cashes in $250M worth of payments for Zolgensma, 2 other gene therapies
Fierce Biotech
Tuesday, May 20, 2025 - 10:18am
tags:
Regenxbio, Novartis, Zolgensma, gene therapy, spinal muscular atrophy
Ionis Builds Triglyceride-Lowering Case for RNA-Targeting Tryngolza
BioSpace
Tuesday, May 20, 2025 - 9:42am
tags:
Ionis Pharmaceuticals, triglycerides, Tryngolza, clinical trials
Countries formally adopt WHO’s Pandemic Agreement for future pandemics
Clinical Trials Arena
Tuesday, May 20, 2025 - 9:39am
tags:
WHO, pandemic
The placebo effect: How a new FDA rule could pile more strain onto vaccine developers
Pharma Voice
Tuesday, May 20, 2025 - 9:37am
tags:
vaccines, R&D, clinical trials, Robert F Kennedy Jr., placebos, FDA
Imec showcases ingestible sensor for gut studies
Pharmaphorum
Tuesday, May 20, 2025 - 9:35am
tags:
Imec, Medtech, nanoelectronics, R&D
Prime Medicine CEO exits as biotech shelves sole clinical gene therapy, lays off 25% of staff
Fierce Biotech
Monday, May 19, 2025 - 10:35pm
tags:
Prime Medicine, gene therapy, layoffs, PM359
Pfizer signs licensing deal worth about $6 billion with China's 3SBio for cancer drug
Yahoo/Reuters
Monday, May 19, 2025 - 10:33pm
tags:
Pfizer, China, 3SBio, cancer, oncology, non-small cell lung cancer, metastatic colorectal cancer
Boehringer details data from pair of Phase III pulmonary fibrosis wins
First Word Pharma
Monday, May 19, 2025 - 10:28pm
tags:
Boehringer Ingelheim, pulmonary fibrosis, clinical trials, nerandomilast
For Eisai and Biogen's Leqembi, first FDA-approved Alzheimer's blood test will take time to boost launch: analyst
Fierce Pharma
Monday, May 19, 2025 - 10:25pm
tags:
Eisai, Biogen, Alzheimer's disease, Leqembi, diagnostics
AstraZeneca's Airsupra cuts risk of severe exacerbations by 47% in patients with milder asthma
Fierce Pharma
Monday, May 19, 2025 - 10:22pm
tags:
AstraZeneca, asthma, Airsupra, clinical trials
Power of collaboration more pertinent than ever says pharma experts
Clinical Trials Arena
Monday, May 19, 2025 - 10:20pm
tags:
collaboration, tariffs, drug pricing, Swiss Biotech Day
Regeneron wins bid to buy 23andMe out of bankruptcy
BioPharma Dive
Monday, May 19, 2025 - 11:29am
tags:
Regeneron, 23andMe, M&A, Medtech, diagnostics, genetic testing
Amid US investment push, Lilly eyes Houston as potential home for $5.9B API plant
Fierce Pharma
Monday, May 19, 2025 - 11:25am
tags:
Eli Lilly, Houston, Texas, drug manufacturing
Ionis announces positive topline results from Essence study of olezarsen in people with moderately elevated triglycerides
BioSpace
Monday, May 19, 2025 - 11:21am
tags:
Ionis Pharmaceuticals, clinical trials, triglycerides, olezarsen
Rejuvenate Biomed doses first subject in COPD-related muscle weakness trial
Clinical Trials Arena
Monday, May 19, 2025 - 11:19am
tags:
Rejuvenate Biomed, RJx-01, COPD

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.